PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Increased Incidence of Peripheral Arterial Disease Support Rising Uptake of Peripheral Stents in Europe - New analysis from Frost & Sullivan, European Peripheral Stents Market, finds that the market earned revenues of $160.7 million in 2006 and estimates this to reach $376.2 million in 2013
Increased Incidence of Peripheral Arterial Disease Support Rising Uptake of Peripheral Stents in Europe

 

NewswireToday - /newswire/ - London, United Kingdom, 2007/11/13 - New analysis from Frost & Sullivan, European Peripheral Stents Market, finds that the market earned revenues of $160.7 million in 2006 and estimates this to reach $376.2 million in 2013.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The European peripheral stents market is in the developmental phase, both in terms of revenue and technology. Improved diagnosis of peripheral arterial disease, greater awareness of this condition and of available treatments will promote market expansion. Studies demonstrating the efficacy of novel product offerings will reinforce growth trends in the market.

New analysis from Frost & Sullivan (medicaldevices.frost.com), European Peripheral Stents Market, finds that the market earned revenues of $160.7 million in 2006 and estimates this to reach $376.2 million in 2013.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the European Peripheral Stents Market, then send an email to Radhika Menon Theodore, Corporate Communications, at rmtheodore[.]frost.com with your full name, company name, title, telephone number and email address. Upon receipt of the above information, an overview will be sent to you by email.

"The move towards minimally invasive surgeries and the rising incidence of peripheral arterial disease has increased the need for stenting," notes Frost & Sullivan Research Analyst Sowmya Rajagopalan. "Research and innovation have been the norm in this developing market, with shortcomings in existing products being rapidly addressed to ensure their success."

At the same time, manufacturers have moved to boost revenues by developing products for new applications. The launch of dedicated below the knee (BTK) stents is the best example of the emergence of new application areas. The need to treat arterial disease in the narrow arteries lying below the knee was studied along with the drawbacks of using coronary stents for this purpose. This led to the need for dedicated stents, resulting in the development of BTK stents.

However, as the use of stents in peripheral applications is new in comparison to coronary stents, and because surgical procedures have been the gold standard for the treatment of peripheral arterial disease, the acceptance of these products has been relatively low. Moreover, a sizeable percentage of the patient base remains untreated, resulting in an under exploitation of the potential patient pool and, in turn, limiting revenues.

"There is a dearth of sufficiently trained surgeons to perform these procedures," says Rajagopalan. "The lack of training is resulting in improper stenting, thereby affecting the success of both the procedures and products."

To promote sustained market expansion, manufacturers should conduct symposiums and workshops to enhance awareness among patients and physicians about peripheral arterial disease and peripheral stents.

European Peripheral Stents Market is part of the Medical Devices Growth Partnership Services program, which also includes research in the following: European Markets for Catheters and Guidewires for Angioplasty and Angiography and European Medical Lasers Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews are available to the press.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Increased Incidence of Peripheral Arterial Disease Support Rising Uptake of Peripheral Stents in Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Radhika Menon Theodore 
rmtheodore[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA
AFC Industries Joins HIMSS for its 56th Edition
Medical Companies Flock to Israel for R&D Support Infrastructure and Inorganic Growth Opportunities Finds Frost & Sullivan
GE Healthcare Expands MRI Contrast Media Product Range in Europe with Launch of Macrocyclic Agent Clariscan
Sparta Systems Launches Product Registration Tracking for 123Compliance Cloud QMS
Frost & Sullivan Lauds SnooZeal’s Unique Electrical Stimulation Therapy for Sleep Apnea in the European Market

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)